Analysis on Medical Cost Control in Chongqing Public Hospitals from 2011 to 2015

DOI

10.2991/assehr.k.200331.111How to use a DOI?

Keywords

public hospital, outpatient expenses, inpatient expenses, medical expenses

Abstract

Based on the analysis of outpatients and inpatients of public hospitals at all levels in Chongqing from 2011 to 2015, this paper combined with a new round of public hospitals reform which beyond the increased rate of medical expenses and the larger proportion of drugs, accounted for a further policy recommendation. The total income balance of 2011—2015 in 16 public hospitals randomly collected in Chongqing, including the related key indicators: the outpatients and inpatients medical expenses per capita, the ratio of drug, which were calculated over the past five years. The proportion of drugs in sampled 16 hospitals in 2011—2015 were increased year by year, with an average increase rate of 32.82%. The outpatient and inpatient’s drug ratio were above 38% in all level of public hospitals; The average OP expenses per capita, respectively by 8.94% and 8.58% growth rate in secondary and tertiary hospitals. In primary hospitals the average inpatient expenses per capita growth rate was 8.39% during survey years. A new round reform of public hospitals in Chongqing has implemented a policy of primary consultation and two-way referral at the grassroots level.

Copyright

© 2020, the Authors. Published by Atlantis Press.

Open Access

This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

TY  - CONF
AU  - Weiwei Liu
AU  - Shan He
AU  - Xin Zhao
AU  - Fang Tan
PY  - 2020
DA  - 2020/04/02
TI  - Analysis on Medical Cost Control in Chongqing Public Hospitals from 2011 to 2015
BT  - Proceedings of the 5th International Conference on Social Sciences and Economic Development (ICSSED 2020)
PB  - Atlantis Press
SP  - 529
EP  - 532
SN  - 2352-5398
UR  - https://doi.org/10.2991/assehr.k.200331.111
DO  - 10.2991/assehr.k.200331.111
ID  - Liu2020
ER  -